2nd TPD Assay Development and Screening Summit

Conference themes
Bringing together technical case studies with actionable insights, the 2nd TPD Assay Development and Screening Summit returns as the first and only industry-dedicated conference to support in-house assay development and screening strategies to find new targets, uncover novel ligands, unravel the MOA, progress beyond CRBN and VHL, improve high throughput methods and progress from early discovery to drug candidate with scalable compounds.

Professional congress organizer (PCO)
Hanson Wade

Notes
URL:
Brochure: https://go.evvnt.com/1854106-3?pid=4832

Speakers: Anand Ramanathan, Associate Director, Lead Discovery, Kymera Therapeutics, Beth Hoffman, Chief Executive Officer, Origami Therapeutics, and more

https://go.evvnt.com/1854106-2?pid=4832

Ms. Isabella Hunter